OOIR: Observatory of International Research

Papers

(The H4-Index of Current Treatment Options in Oncology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer	96
Role of Metastasis-Directed Therapy in Genitourinary Cancers	71
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies	68
An Update on Temporal Bone Paragangliomas	66
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes	65
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer	53
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia	51
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect	50
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead	48
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma	48
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)	43
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T	41
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?	39
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?	38
Approach to Localized Squamous Cell Cancer of the Esophagus	37
Small Cell Lung Cancer—An Update on Chemotherapy Resistance	35
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer	34
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers	34
The Role of Nursing in the Delivery of Cardio-Oncology	31
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma	29
Management of Fatigue in Patients with Advanced Cancer	28
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management	28
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements	28
Regorafenib for the Treatment of Sarcoma	27
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer	26

Advances in Targeted Therapy for Metastatic Prostate Cancer	25
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?	25